Literature DB >> 14499141

The value of positron emission tomography for monitoring response to radiotherapy in head and neck cancer.

Bianca M Klabbers1, Adriaan A Lammertsma, Ben J Slotman.   

Abstract

Positron emission tomography (PET) is a molecular imaging technique that allows for accurate measurements of specific tissue functions. Staging of cancer using 2-deoxy-2-[18F]fluoro-D-glucose (FDG) is the most widely used diagnostic application. As PET is able to measure functional changes quantitatively, interest is growing in its use for monitoring response to therapy. This review describes both biologic characteristics of FDG and methodologic issues regarding its use in the head and neck region. In addition, the potential use of FDG for predicting and monitoring response to radiotherapy is discussed. Finally, the potential of some other tracers for monitoring response is reviewed.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14499141     DOI： 10.1016/s1536-1632(03)00102-1

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN： 1536-1632            Impact factor:   3.488


  8 in total

1.  [PET/CT in radiotherapy].

Authors:  M Weckesser; S Könemann; M Brinkmann; N Willich; O Schober
Journal:  Radiologe       Date:  2004-11       Impact factor: 0.635

2.  Clinical value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating relapsed and refractory nasopharyngeal carcinoma: A case report.

Authors:  Zejun Lu; Xiangfei Zhao; Henghu Fang; Sudong Wu; Juyi Wen; Xinhong Zhang; Jingbo Kang
Journal:  Mol Clin Oncol       Date:  2015-02-09

3.  Response evaluation after chemoradiotherapy for advanced staged oropharyngeal squamous cell carcinoma: a nationwide survey in the Netherlands.

Authors:  Charlotte S Schouten; Otto S Hoekstra; C René Leemans; Jonas A Castelijns; Remco de Bree
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-06       Impact factor: 2.503

4.  Comparison of FLT-PET and FDG-PET for visualization of head and neck squamous cell cancers.

Authors:  Hiroshi Hoshikawa; Yoshihiro Nishiyama; Takehito Kishino; Yuka Yamamoto; Reiji Haba; Nozomu Mori
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

5.  PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma.

Authors:  Shu-Hang Ng; Sheng-Chieh Chan; Tzu-Chen Yen; Chun-Ta Liao; Chin-Yu Lin; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Hung-Ming Wang; Kai-Ping Chang; Kang-Hsing Fan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-15       Impact factor: 9.236

6.  Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2'-deoxy-2'-[18F]fluoro-D-glucose (FDG) and 3'-[18F]fluoro-3'-deoxythymidine (FLT).

Authors:  Carla F M Molthoff; Bianca M Klabbers; Johannes Berkhof; Jasper T Felten; Marcelle van Gelder; Albert D Windhorst; Ben J Slotman; Adriaan A Lammertsma
Journal:  Mol Imaging Biol       Date:  2007 Nov-Dec       Impact factor: 3.488

7.  Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.

Authors:  R M Subramaniam; M Truong; P Peller; O Sakai; G Mercier
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-12       Impact factor: 3.825

8.  Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Authors:  Akram Al-Ibraheem; Andreas Buck; Bernd Joachim Krause; Klemens Scheidhauer; Markus Schwaiger
Journal:  J Oncol       Date:  2009-08-20       Impact factor: 4.375
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.